20.83
                                            Schlusskurs vom Vortag:
              $19.61
            Offen:
              $19.72
            24-Stunden-Volumen:
                83,663
            Relative Volume:
              0.23
            Marktkapitalisierung:
                $386.06M
            Einnahmen:
              $62.81M
            Nettoeinkommen (Verlust:
              $-13.75M
            KGV:
              -26.04
            EPS:
                -0.8
            Netto-Cashflow:
                $153.00K
            1W Leistung:
              -4.08%
            1M Leistung:
              +1.44%
            6M Leistung:
                +128.02%
            1J Leistung:
              +298.37%
            Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
                  
                      Optimizerx Corp
                    
                Sektor
                  Branche
                  Telefon
                  
                      248-651-6558
                    
                Adresse
                  
                      260 CHARLES STREET, WALTHAM, MI
                    
                Vergleichen Sie OPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                OPRX
                            
                             Optimizerx Corp | 20.80 | 364.06M | 62.81M | -13.75M | 153.00K | -0.80 | 
|   
                          
                                VEEV
                            
                             Veeva Systems Inc | 289.52 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 | 
|   
                          
                                TEM
                            
                             Tempus Ai Inc | 89.45 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 | 
|   
                          
                                DOCS
                            
                             Doximity Inc | 66.71 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 | 
|   
                          
                                HQY
                            
                             Healthequity Inc | 94.78 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 | 
|   
                          
                                WAY
                            
                             Waystar Holding Corp | 37.27 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 | 
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform | 
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight | 
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy | 
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight | 
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy | 
| 2022-11-01 | Eingeleitet | Stifel | Buy | 
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform | 
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy | 
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2019-01-03 | Eingeleitet | William Blair | Outperform | 
                    Alle ansehen
                     
                  
                Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corporation stock chart pattern explained2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Why OptimizeRx Corporation stock attracts global investorsShare Buyback & Capital Protection Trading Alerts - newser.com
OptimizeRx (NASDAQ: OPRX) sets Q2 results call Aug 7 via webcast and dial-in access - Stock Titan
OptimizeRx Corp. Hits New 52-Week High of $21.99, Up 90% Yearly - Markets Mojo
Can OptimizeRx Corporation stock attract ESG capital inflowsJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com
OptimizeRx Corporation stock outlook for YEARWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
Why OptimizeRx Corporation stock appeals to analystsWeekly Gains Report & Weekly Market Pulse Alerts - newser.com
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
What insider trading reveals about OptimizeRx Corporation stockPortfolio Value Report & Capital Efficient Trade Techniques - Fundação Cultural do Pará
Aug Outlook: Why OptimizeRx Corporation stock appeals to analystsJobs Report & Free Safe Capital Growth Stock Tips - Fundação Cultural do Pará
Why analysts upgrade OptimizeRx Corporation stockEarnings Overview Summary & Safe Capital Preservation Plans - Fundação Cultural do Pará
Is now a turning point for OptimizeRx CorporationJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Will OptimizeRx Corporation stock recover faster than marketJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Is OptimizeRx Corporation stock recession proofJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Is OptimizeRx Corporation stock in correction or buying zoneNew Guidance & Safe Entry Trade Reports - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx Stock Delivers Over 90% Gain In Six MonthsA Prescription For Portfolio Growth? - RTTNews
Pattern recognition hints at OptimizeRx Corporation upsideStock Surge & Reliable Momentum Entry Alerts - newser.com
Does OptimizeRx Corporation qualify in momentum factor screening2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Real time social sentiment graph for OptimizeRx CorporationJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET - The Globe and Mail
OptimizeRx Corp. Schedules Conference Call to Discuss Q3 2025 Financial Results - Quiver Quantitative
Nov 6, 4:30 p.m. ET: OptimizeRx to Discuss Q3 2025 Results on Conference Call; replay 12 months - Stock Titan
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optimizerx Corp-Aktie (OPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt | 
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Executive Officer | Oct 03 '25 | Option Exercise | 0.00 | 6,649 | 0 | 190,536 | 
| Silvestro Stephen L | Chief Executive Officer | Oct 03 '25 | Sale | 18.75 | 1,620 | 30,375 | 188,916 | 
| Stelmakh Edward | Chief Finance & Strat Officer | Oct 03 '25 | Option Exercise | 0.00 | 16,623 | 0 | 127,387 | 
| Besch Doug | Chief Product & Tech Officer | Oct 03 '25 | Option Exercise | 0.00 | 3,325 | 0 | 70,555 | 
| Spangler Patrick D | Director | Aug 28 '25 | Sale | 17.49 | 11,120 | 194,489 | 44,215 | 
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App